Understanding and Working With New Immunotherapeutic and Targeted Management Models in Advanced RCC

Navigating Evolving Standards of Care in RCC: Novel Targeted and Immunotherapy OptionsПодробнее

Advanced RCC Treatment SelectionПодробнее

Immunotherapy/TKI Combinations in Advanced RCCПодробнее

RCC MasterClass and Clinical Consult: Novel Immune and Targeted TherapiesПодробнее

Immunotherapy and targeted therapy for advanced aRCCПодробнее

Selecting and Sequencing Targeted and Immunotherapy Regimens for Patients With RCCПодробнее

Immunotherapy-based combinations for advanced/metastatic renal cell carcinoma: ASCO GU 2023Подробнее

RCC: Current Applications, Controversies, and Future Use of Immunotherapy and Targeted AgentsПодробнее

Immunotherapy-based management of metastatic clear-cell and variant RCC: What can we achieve?Подробнее

Case-Based Tumor Board: Confronting Management Controversies in Renal Cell CarcinomaПодробнее

Dr. Hammers on the Future of Immunotherapy in RCCПодробнее

Clinically Meaningful Outcomes Among Expanding Treatment Options in RCCПодробнее

Dr. McGregor on New Combinations With Immunotherapy in RCCПодробнее

Managing Advanced Renal Cell Carcinoma - QuinnПодробнее

Immunotherapy Combinations Improve Survival in Advanced Renal Cell CarcinomaПодробнее

Dr. Motzer on the Milestone of Immunotherapy in RCCПодробнее

Immunotherapy and targeted therapy for advanced aRCCПодробнее

Guidelines Based Management of Localized and Locally Advanced RCCПодробнее

Immunotherapy in Renal Cell CarcinomaПодробнее

Understanding Immunotherapy in Treatment for Kidney CancerПодробнее